NCT00394277 - A Study of Induction Dosing With PEGASYS (Peginterferon Alfa-2a [40KD]) Plus Copegus in Treatment-Naive Patients With Chronic Hepatitis C | Biotech Hunter

Enrollment

1,175

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions

Hepatitis C, Chronic

Interventions

DRUG

peginterferon alfa-2a

180 µg sc weekly for 48 weeks

DRUG

Ribavirin

1200 mg po daily for 48 weeks

DRUG

peginterferon alfa-2a

360 µg sc weekly decreasing to 180 µg sc weekly for 48 weeks

DRUG

Ribavirin

1400-1600 mg po daily for 48 weeks

Trial Locations (184)

1000

Brussels

1030

Brussels

1070

Brussels

1083

Budapest

1097

Budapest

1200

Brussels

3000

Leuven

4032

Debrecen

5000

Odense

5600

Békéscsaba

5700

Gyula

6000

Kolding

7654

Pécs

9000

Ghent

9024

Győr

9700

Szombathely

10021

New York

10029

New York

10467

The Bronx

10701

Yonkers

11030

Manhasset

13353

Berlin

14221

Williamsville

14618

Rochester

15213

Pittsburgh

19104

Philadelphia

19107

Philadelphia

20010

Washington D.C.

20037

Washington D.C.

20246

Hamburg

22003

Annandale

22031

Fairfax

23249

Richmond

24105

Kiel

28304

Fayetteville

28801

Asheville

29204

Columbia

30060

Marietta

30106

Austell

30308

Atlanta

30625

Hanover

32209

Jacksonville

32256

Jacksonville

33162

North Miami Beach

34243

Sarasota

35294

Birmingham

35392

Giessen

35801

Huntsville

37205

West Nashville

38138

Germantown

40202

Louisville

40225

Düsseldorf

44106

Cleveland

44109

Cleveland

45267

Cincinnati

46202

Indianapolis

48197

Ypsilanti

48210

Detroit

50312

Des Moines

50924

Cologne

52246

Iowa City

55446

Plymouth

59037

Lille

60190

Winfield

60590

Frankfurt am Main

60612

Chicago

60637

Chicago

63000

Clermont-Ferrand

63104

St Louis

63110

St Louis

64131

Kansas City

67091

Strasbourg

69120

Heidelberg

69288

Lyon

70112

New Orleans

70805

Baton Rouge

72076

Tübingen

74104

Tulsa

75185

Uppsala

75203

Dallas

75246

Dallas

76031

Rouen

77030

Houston

79106

Freiburg im Breisgau

80045

Aurora

80113

Englewood

82001

Cheyenne

82609

Casper

84121

Salt Lake City

85006

Phoenix

90045

Los Angeles

90095

Los Angeles

92069

San Marcos

92105

San Diego

92118

Clichy

92123

San Diego

92154

San Diego

93003

Ventura

93401

San Luis Obispo

93534

Lancaster

93721

Fresno

95817

Sacramento

96817

Honolulu

97504

Medford

98104

Seattle

98405

Tacoma

98664

Vancouver

99508

Anchorage

105229

Moscow

115446

Moscow

117333

Moscow

119881

Moscow

127009

Moscow

143420

Moscow

194044

Saint Petersburg

214006

Smolensk

355017

Stavropol

443011

Samara

531105

Bonn

603022

Nizhny Novgorod

700111

Iași

92037-1030

La Jolla

92103-8465

San Diego

33136-1051

Miami

52242-1081

Iowa City

02720

Boston

01068

Worcester

03756

Lebanon

08234

Egg Harbour Township

08360

Vineland

27599-7080

Chapel Hill

17604-3200

Lancaster

02920

Cranston

02903

Providence

75390-9034

Dallas

78234-3879

Fort Sam Houston

22906-0013

Charlottesville

23320-1706

Chesapeake

18618-970

Caixa

13083-888

Campinas

36036-330

Juiz de Fora

90035-003

Porto Alegre

91350-200

Porto Alegre

40110-170

Salvador

15090-000

São José do Rio Preto

01307

São Paulo

T6G 2B7

Edmonton

V6Z 2K5

Vancouver

R3E 3P4

Winnipeg

B3H 1V7

Halifax

N6A 5A5

London

K1H 8L6

Ottawa

M5G 1L7

Toronto

M5G 1X5

Toronto

M6H 3M1

Toronto

H1T 2M4

Montreal

1091 AC

Amsterdam

2333 ZA

Leiden

3015 GD

Rotterdam

85-030

Bydgoszcz

41-500

Chorzów

25-317

Kielce

91-347

Lodz

01-201

Warsaw

51-124

Wroclaw

00716

Ponce

00936-5067

San Juan

00909

Santurce

010825

Bucharest

021105

Bucharest

022328

Bucharest

030303

Bucharest

Unknown

Cluj-Napoca

Constanța

Timișoara

Jaloslave

Stockholm

11/5

Moscow

SE5 9RS

London

SW10 9TH

London

SW17 0QT

London

NE7 7DN

Newcastle upon Tyne

PL6 8DH

Plymouth

SO16 6YD

Southampton

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY